About Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica
During the past decade, Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica" are
"Prostate Cancer" (2 trials), "Cancer of the Prostate" (1 trials) and "Nonmetastatic Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica
Most popular intervention types in "Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Enzalutamide" (2 trials), "Abiraterone" (1 trials), "Placebo" (1 trials), "Placebo for Enzalutamide" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica
The vast majority of trials in "Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica" are
2 trials for "Male" genders.
Clinical Trials Status at Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica
Currently, there are NaN active trials in "Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Azienda Ospedaliera S. Camillo Forlanini, UOC per il governo clinico in Oncologia Medica, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".